Frontiers in Cellular and Infection Microbiology

Frontiers in Cellular and Infection Microbiology (FRONT CELL INFECT MI, ISSN: 2235-2988) is a leading open-access journal published by Frontiers Media SA, dedicated to advancing the understanding of host-pathogen interactions at the cellular and molecular level. The journal’s scope encompasses all aspects of cellular microbiology and infectious disease research, including bacterial, viral, fungal, and parasitic infections, as well as the host immune response, microbiota-host crosstalk, antimicrobial resistance, and the development of novel therapeutic and diagnostic strategies. It covers a broad range of topics such as intracellular pathogenesis, biofilm formation, microbial genomics, and the role of the microbiome in health and disease. The journal publishes a diverse array of article types, including original research articles, comprehensive reviews, mini-reviews, perspectives, and commentaries, as well as specialized formats like method articles and technology reports. Its primary target audience comprises microbiologists, immunologists, infectious disease specialists, cell biologists, and clinicians seeking cutting-edge insights into infection mechanisms and host defense. Notably, Frontiers in Cellular and Infection Microbiology operates under a rigorous open-access model, ensuring that all published content is freely available to the global research community, thereby maximizing dissemination and impact. With a 2026 Impact Factor of 5.5000 and a JCR Quartile ranking of Q1, the journal stands as a highly regarded venue in the fields of microbiology and infectious diseases, consistently placing among the top-tier publications. This strong citation performance and broad readership underscore its reputation as a key platform for high-quality, peer-reviewed research that bridges fundamental cellular biology and clinical infection management.